In the recent ELN-recommendation, RUNX1 mutation was stated as a late event in leukaemia development [21], which contradicts earlier studies, considering RUNX1 mutations as early events in leukemognenesis [15, 50]. This evidence concerns the gene RUNX1 and leukemia.